LAP announced it has strengthened its partnership with leading integrated oncology care provider, GenesisCare, to continue providing advanced treatment planning software in radiation oncology centers around the globe.

August 3, 2021 — LAP announced it has strengthened its partnership with leading integrated oncology care provider, GenesisCare, to continue providing advanced treatment planning software in radiation oncology centers around the globe.

As the complexity of treatment planning in radiation oncology increases, it is imperative for physicians and radiation therapists to have confidence in the accuracy of secondary dose verification. RadCalc’s independent 3D calculations has allowed GenesisCare and other providers a more accurate analysis of the dose being delivered to their patients with customizable automation designed to fit any clinical workflow.

GenesisCare will continue to employ RadCalc in 173 radiation oncology sites across Australia, the United Kingdom, Spain and the United States, with room for further expansion to other sites in the future. Included in the agreement is also RadCalc’s 3D premium for the UK region and GammaKnife solution.

GenesisCare is the world’s largest provider of radiotherapy – an important treatment option for cancer patients – and provides patients with access to diagnostics, medical oncology, surgical oncology, radiotherapy, and novel therapies alongside the ability to participate in the latest clinical trials.

“RadCalc is a comprehensive treatment plan analysis tool that ensures our patients receive the highest quality precision care and treatment plans that have the best chance of improving patient outcomes,” said Tim Fox, GenesisCare’s Global Head of Medical Physics and Clinical Technology.

With their collaboration both parties aim to enhance safety and efficiency in radiation oncology.

For more information: www.lap-laser.com

Related Content

News | Proton Therapy

July 1, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology ...

Time July 01, 2022
arrow
News | Prostate Cancer

July 1, 2022 — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care ...

Time July 01, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

June 30, 2022 — When a patient with head and neck cancer has surgery to remove it, they often need reconstructive ...

Time June 30, 2022
arrow
News | Proton Therapy

June 29, 2022 — ProtOnART builds upon the partners’ long-standing research efforts and shared ambition that an online ...

Time June 29, 2022
arrow
News | Lung Imaging

June 29, 2022 — Building on Penn Medicine’s years of research and use of imaging technology that illuminates tumor ...

Time June 29, 2022
arrow
News | Proton Therapy

June 27, 2022 — Varian, a Siemens Healthineers company, announced that the U.S. Food and Drug Administration (FDA) ...

Time June 28, 2022
arrow
News | Radiation Oncology

June 27, 2022 — Neutron Therapeutics, Inc (NT) and the University Hospital of Brussels (H.U.B) today announced that they ...

Time June 28, 2022
arrow
News | Radiation Therapy

June 24, 2022 — Recently, a collaborated research team led by Prof. LI Hai and Hongzhi Wang from Hefei Institutes of ...

Time June 24, 2022
arrow
News | Radiation Therapy

June 23, 2022 — RaySearch Laboratories AB announced the release of the latest version of RayCare*, the next generation ...

Time June 23, 2022
arrow
News | Radiation Therapy

June 17, 2022 — Accuray Incorporated and Limbus AI Inc. announced they are partnering to augment Accuray adaptive ...

Time June 17, 2022
arrow
Subscribe Now